Association of postoperative haemoglobin with adverse outcomes in patients undergoing cardiac surgery: a...

Preoperative anaemia is an important risk factor for adverse outcomes in cardiac surgery, however data on postoperative anaemia is sparse. The aim of this study is to characterise the association of postoperative haemoglobin with 30-day mortality and morbidity after cardiac surgery.

We performed a retrospective cohort study of adults (age ≥18 yr) undergoing coronary revascularisation, valve surgery, or a combination at Toronto General Hospital from 2016 to 2020. We analysed the association between nadir postoperative day 1 (POD1) haemoglobin as a continuous and binary variable (haemoglobin ≤80 g L^-1), with a primary composite outcome of 30-day mortality, stroke, myocardial infarction, acute kidney injury, sternal wound infection, or a combination. The secondary outcome was the incidence of adverse events. The primary outcome was analysed using logistic regression, secondary using Poisson regression; adjusted models accounted for clustering and confounders.

We included 5960 patients. On POD1, mean haemoglobin was 90.1g L^-1 (standard deviation 15.2) and 1794 patients (30%) had haemoglobin ≤80 g L^-1. Red blood cells were transfused to 49% of the cohort, and to 90% of patients with POD1 haemoglobin ≤80 g L^-1. Each 10 g L^-1 decrease in POD1 haemoglobin increased the odds of the primary outcome (adjusted odds ratio [OR] 1.15 [1.05-1.25], P<0.001), as did haemoglobin ≤80 g L^-1 (adjusted OR 1.44 [1.19-1.75], P<0.001). For adverse events, each 10 g L^-1 decrease in haemoglobin was associated with an increased incidence rate ratio (IRR) (adjusted IRR 1.14 [1.07-1.20], P<0.001), as was haemoglobin <80 g L^-1 (adjusted IRR 1.33 [1.16-1.54], P<0.001).

In postoperative cardiac surgical patients, progressive decreases in postoperative haemoglobin are associated with increased risk of mortality and major morbidity at 30 days.